

The results of almost 1,600 individuals with a first episode of psychosis who had undergone an MRI brain scan were analyzed by researchers led by Dr Graham Blackman and Professor Philip McGuire at the University of Oxford.
They discovered that approximately 6% of patients had a scan abnormality, which resulted in a new diagnosis or a change in their therapeutic management.
Dr Blackman, an NIHR (National Institute for Health and Care Research) Clinical Lecturer at the University, says:“Patients presenting with psychosis may have another physical illness or condition causing their symptoms that can be identified using MRI scanning. A failure to detect these causes at an early stage can have serious consequences, such as a delay in providing the appropriate treatment.”
“Our findings suggest that MRI scans should be considered as part of the initial assessment of all people with first-episode psychosis to ensure that they get the right diagnosis and the right treatment.”
Although performing a brain scan on new patients with psychosis is considered best practice, it is not required. Previously, a NICE Technology Appraisal was unable to suggest scanning in all patients since it was unclear at the time how common clinically important brain abnormalities are in persons with first-episode psychosis.
Prof McGuire added: “We feel that this study addresses a critical knowledge gap in this area by showing that clinically relevant abnormalities occur frequently enough to justify making MRI scanning a routine part of the assessment of people presenting with psychosis for the first time. This new evidence has important implications for clinical care in psychosis and a review of the NICE guidance in this area would be helpful.”
more recommended stories
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Toxic Soil and Water Linked to Global Heart Disease Crisis
A groundbreaking review published in Atherosclerosis.
Women’s Health: 195 New Genetic Risks Revealed
In a groundbreaking study published in.
Cytomegalovirus Transmission – New Study Uncovers Key to Prevention
A groundbreaking study co-authored by Weill.
Top 10 Spring CME/CE Conferences in USA – 2025
Staying up to date with the.
Semen Quality as a Predictor of Long-Term Health
A landmark study published in Human.
HPV-Negative Head & Neck Cancer: Hope in Immunotherapy
A groundbreaking Phase 2 clinical trial.
Leave a Comment